
sganguly
@bmtdoc63
Hematologic Malignancy and Cellular Therapeutics
ID: 2185201146
09-11-2013 23:14:46
972 Tweet
1,1K Followers
461 Following


Infection after CD19 chimeric antigen receptor T cell therapy for large B cell lymphoma: Real-world analysis from CIBMTR | Blood Advances | American Society of Hematology Kitsada Wudhikarn ashpublications.org/bloodadvances/…






Enjoying, learning. getting amazed by the great works being done at the #CellAndGeneTherapy center Faculty of Medicine, Chulalongkorn U.. Great way to spend a #happy4thofjuly2025. Thank you Chulalongkorn U. for inviting me.








🧵 Long-term Outcomes in AL Amyloidosis Patients Undergoing Heart Transplant 1/🫀💡 Think AL amyloidosis = poor heart transplant outcomes? Think again. A new single-center study from Houston Methodist (2009–2023) shows comparable survival in AL patients vs non-AL heart transplant
